Baseline serum AQP4 levels in AIS patients undergoing thrombolysis inversely correlated with neurological severity and infarct size, with higher levels associated with better recovery outcomes, suggesting its potential as a prognostic biomarker for recovery [270]. Here, AQP4 is linked to androgen insensitivity syndrome.